The University and the Wallace H. Coulter Foundation have partnered to create a $20 million endowment which will fund the University of Virginia Coulter Translational Research Partnership in biomedical engineering. This aims to foster research collaboration between biomedical engineers and clinicians with the ultimate goal of bringing new technology for human health to the marketplace.
The funds will go toward translational research, which works to apply discoveries from University laboratories to the creation of products or services, often by working in partnership with corporations or creating small companies.
In 2005 the Foundation chose the University as one of nine to receive $5 million grants during a five-year period, said Thomas Skalak, Coulter program leader and vice president for research at the University. The money is meant to accelerate the movement of University biomedical engineering projects into commercial products and clinical practices.
"Because of its demonstrated success, U.Va. was selected for the new endowment to continue the program in perpetuity, along with Stanford, Duke, Michigan, and Drexel," Skalak said in a statement, adding that the Coulter Foundation also endows Georgia Tech for translational research.
In addition to Skalak, University team leaders include David Chen, the University's Coulter program director, Michael Lawrence, the interim chair of Biomedical Engineering and Sharon Krueger, the University innovation partnership coordinator. The advisory board for the partnership is